Identification of TMEM230 mutations in familial Parkinson’s disease
暂无分享,去创建一个
M. Pericak-Vance | J. Jankovic | B. Ghetti | J. Vance | D. Nicholson | K. Ahmeti | N. Siddique | T. Siddique | D. Krainc | T. Foroud | A. Rajput | Nimrod Miller | H. Deng | H. Deng | Yongchao C. Ma | Yan-ming Xu | K. Nuytemans | Zhi Song | Cao Huang | Bo Huang | F. Fecto | Yi Yang | H. Zhai | O. Melen | Zhenhua Liu | Yong Shi | B. Tang | Xiao-ping Gao | Nicola J. Corbett | Lijun Cheng | Sheng Deng | Myung Jong Kim | Ziquang Yang | Piao Chen | Kreshnik B. Ahmeti | Karen Nuytemans | Faisal Fecto
[1] T. Postmus. Genetics of Parkinson's disease , 2018 .
[2] Xinglong Yang,et al. Sequence TMEM230 gene in patients with multiple system atrophy in a southwest Chinese population: A pilot study , 2017, Journal of the Neurological Sciences.
[3] Xinglong Yang,et al. Sequencing TMEM230 in Chinese patients with sporadic or familial Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[4] Dimitri Krainc,et al. The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking , 2017, Human molecular genetics.
[5] K. Lohmann,et al. Evaluating the role of TMEM230 variants in Parkinson's disease. , 2017, Parkinsonism & related disorders.
[6] M. Farrer,et al. Conjugal parkinsonism - Clinical, pathology and genetic study. No evidence of person-to-person transmission. , 2016, Parkinsonism & Related Disorders.
[7] Y. Dauvilliers,et al. Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease , 2016, Neurobiology of Aging.
[8] Matthias Mann,et al. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases , 2016, eLife.
[9] Key mendelian variants , 2015, Nature Genetics.
[10] J. Langston,et al. Multisystem Lewy body disease and the other parkinsonian disorders , 2015, Nature Genetics.
[11] M. Dorschner,et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease , 2015, Molecular Neurodegeneration.
[12] R. Petersen,et al. DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients , 2015, European journal of neurology.
[13] Martin J. McKeown,et al. DNAJC13 genetic variants in parkinsonism , 2015, Movement disorders : official journal of the Movement Disorder Society.
[14] P. Lockhart,et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology. , 2014, American journal of human genetics.
[15] S. Blanton,et al. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. , 2014, Brain : a journal of neurology.
[16] H. Shill,et al. Concomitant pathologies among a spectrum of parkinsonian disorders. , 2014, Parkinsonism & related disorders.
[17] H. Liany,et al. DNAJ mutations are rare in Chinese Parkinson's disease patients and controls , 2014, Neurobiology of Aging.
[18] Wyeth W Wasserman,et al. DNAJC13 mutations in Parkinson disease. , 2014, Human molecular genetics.
[19] Michael D. Pluth,et al. Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons , 2013, Science.
[20] Daniel F Tardiff,et al. Yeast Reveal a “Druggable” Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons , 2013, Science.
[21] S. Pappatà,et al. Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism , 2013, Human mutation.
[22] Vladimir Makarov,et al. The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures , 2013, Human mutation.
[23] M. Farrer,et al. Advances in the genetics of Parkinson disease , 2013, Nature Reviews Neurology.
[24] Katherine H. Schreiber,et al. When Lamins Go Bad: Nuclear Structure and Disease , 2013, Cell.
[25] Eden R Martin,et al. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease , 2013, Neurology.
[26] Jian Peng,et al. Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.
[27] K. Kaestner,et al. A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism , 2012, PloS one.
[28] Michael K. Hutchinson,et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.
[29] I. Martin,et al. Recent advances in the genetics of Parkinson's disease. , 2011, Annual review of genomics and human genetics.
[30] A. Lang,et al. The curious case of phenocopies in families with genetic Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[31] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[32] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[33] Marc N. Offman,et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.
[34] Sonja W. Scholz,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2010, Neuron.
[35] Ted M. Dawson,et al. Genetic Animal Models of Parkinson's Disease , 2010, Neuron.
[36] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[37] M. Martina,et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4 , 2010, Nature Genetics.
[38] V. Di Lazzaro,et al. Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis , 2009, Neurological Sciences.
[39] P. Andersen,et al. Age and founder effect of SOD1 A4V mutation causing ALS , 2009, Neurology.
[40] J. Caviston,et al. Huntingtin as an essential integrator of intracellular vesicular trafficking. , 2009, Trends in cell biology.
[41] E. Rogaeva,et al. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion , 2009, Neurology.
[42] M. Poo,et al. A Selective Filter for Cytoplasmic Transport at the Axon Initial Segment , 2009, Cell.
[43] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[44] M. Farrer,et al. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. , 2008, Parkinsonism & related disorders.
[45] D. Hernandez,et al. Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.
[46] M. Ronaghi,et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.
[47] M. Farrer,et al. Genomic investigation of α‐synuclein multiplication and parkinsonism , 2008, Annals of neurology.
[48] C. Lautier,et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.
[49] M. Farrer,et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.
[50] J. Cappell,et al. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy , 2006, Neurology.
[51] M. Farrer,et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology , 2006, Neurology.
[52] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[53] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Schulz,et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.
[55] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[56] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[57] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[58] D W Dickson,et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology , 2004, Neurology.
[59] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[60] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[61] J. Trojanowski,et al. Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.
[62] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[63] J. Trojanowski,et al. Concurrence of α-synuclein and tau brain pathology in the Contursi kindred , 2002, Acta Neuropathologica.
[64] M. Farrer,et al. Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p , 2000, Acta Neuropathologica.
[65] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[66] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[67] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[68] A. Al-Chalabi,et al. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: Analysis of 155 cases and identification of novel insertion mutation , 1997, Annals of neurology.
[69] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[70] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[71] W. Robberecht,et al. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis , 1996, Neurology.
[72] J. Tainer,et al. The D90A mutation results in a polymorphism of Cu,Zn superoxide dismutase that is prevalent in northern Sweden and Finland. , 1995, Human molecular genetics.
[73] P. Andersen,et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase , 1995, Nature Genetics.
[74] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[75] Kai Simons,et al. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway , 1992, Cell.
[76] R. Uitti,et al. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei , 1989, Annals of neurology.
[77] G. Lathrop,et al. Easy calculations of lod scores and genetic risks on small computers. , 1984, American journal of human genetics.
[78] H. Braak,et al. 100 years of Lewy pathology , 2013, Nature Reviews Neurology.
[79] M. Sternberg,et al. Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.
[80] T. Sudhof,et al. The synaptic vesicle cycle. , 2004, Annual review of neuroscience.
[81] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[82] J. Trojanowski,et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. , 2002, Acta neuropathologica.
[83] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[84] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.